2015Journal of the American College of CardiologyOpen access

PRASUGREL VERSUS ADJUSTED HIGH-DOSE CLOPIDOGREL IN PATIENTS WITH HIGH ON-CLOPIDOGREL PLATELET REACTIVITY: THE PECS-HPR RANDOMIZED, MULTICENTER STUDY

Dániel Aradi, Ferenc Nagy, Géza Lupkovics, Tünde Pintér, Balázs Magyari, Attila Kónyi, Imre Ungi, Iván Horváth, Dobri Hazarbasanov, András Komócsi

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Prasugrel, Clopidogrel, Platelet, Randomized controlled trial, Internal medicine, Multicenter study, Loading dose

Related papers

Back to paper searchBrowse research topicsOriginal source
PRASUGREL VERSUS ADJUSTED HIGH-DOSE CLOPIDOGREL IN PATIENTS WITH HIGH ON-CLOPIDOGREL PLATELET REACTIVITY: THE PECS-HPR RANDOMIZED, MULTICENTER STUDY — Research Paper | ScholarLens